Cereno Insights Series: Sten R. Sörensen’s journey to become CEO of Cereno

Sten R. Sörensen, CEO of Cereno, speaks about his journey to become the CEO of Cereno and why the company’s focus areas – PAH and thrombosis – are highly relevant. In particular, he speaks around the following questions:

• What was your journey to become CEO of Cereno?
• Why is thrombosis such an important area for new drug development?
• Why is pulmonary arterial hypertension (PAH) such an important area for Cereno?

(Recorded at the ESC Congress in August 2022)

Watch here >